Across TCGA pan-cancer cohorts, GAPDHP15 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of GAPDHP15’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where GAPDHP15 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types GAPDHP15 is over-expressed in tumor, although a few such as KIRC and BRCA show the opposite, repressed pattern.

HNSC, KIRC, and BRCA are the cancer types where GAPDHP15 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in GAPDHP15 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	Male	II,III,IV	+0.036	.007	6	view →
KIRC	Female	IV	−0.108	.011	3	view →
BRCA	All	III,IV	−0.083	.011	2	view →
LUAD	All	All	+0.129	.047	1	view →
KICH	All	All	−0.046	.006	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

Exploration

Same gene, other analysis: GAPDHP15 RNA expression & survival · all GAPDHP15 data types